Shandong Xinhua LuKang Pharmaceutical

Shandong Xinhua Lukang Pharmaceutical Co., Ltd., established in 2002 and headquartered in Jinan, China, is a pharmaceutical company that operates as a Marketing Authorization Holder (MAH) and distributor. Originally focused on pharmaceutical wholesale, the company transitioned in 2017 to include drug research, development, and production management. Its product portfolio covers several therapeutic areas, including cardiovascular, gastrointestinal, anti-inflammatory, and allergy treatments. Key products include Olmesartan Medoxomil tablets, Methylprednisolone tablets, and recently approved generics such as Desloratadine oral solution and Sodium Potassium Polyethylene Glycol powder. The company leverages a robust marketing network across China and maintains partnerships for contract manufacturing. It is part of the broader pharmaceutical ecosystem in Shandong province, sharing heritage with major industry players under the Hualu Holdings group.